These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27550507)

  • 21. The routine and the traumatic in prenatal genetic diagnosis: does clinical information inform patient decision-making?
    Hunt LM; de Voogd KB; Castañeda H
    Patient Educ Couns; 2005 Mar; 56(3):302-12. PubMed ID: 15721973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The clinical utility of whole-exome sequencing in the context of rare diseases - the changing tides of medical practice.
    Nguyen MT; Charlebois K
    Clin Genet; 2015 Oct; 88(4):313-9. PubMed ID: 25421945
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of patient participation direct enhanced service on patient reference groups in primary care: a qualitative study.
    Pollard L; Agarwal S; Harrad F; Lester L; Cross A; Wray P; Smith G; Locke A; Sinfield P
    Qual Prim Care; 2014; 22(4):189-99. PubMed ID: 25695530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attitudes of nearly 7000 health professionals, genomic researchers and publics toward the return of incidental results from sequencing research.
    Middleton A; Morley KI; Bragin E; Firth HV; Hurles ME; Wright CF; Parker M;
    Eur J Hum Genet; 2016 Jan; 24(1):21-9. PubMed ID: 25920556
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-genome and whole-exome sequencing in hereditary cancer: impact on genetic testing and counseling.
    O'Daniel JM; Lee K
    Cancer J; 2012; 18(4):287-92. PubMed ID: 22846728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Informed decision making regarding antenatal screening for fetal abnormality in the United Kingdom: a qualitative study of parents and professionals.
    Barr O; Skirton H
    Nurs Health Sci; 2013 Sep; 15(3):318-25. PubMed ID: 23347127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exome sequencing for prenatal diagnosis of fetuses with sonographic abnormalities.
    Drury S; Williams H; Trump N; Boustred C; ; Lench N; Scott RH; Chitty LS
    Prenat Diagn; 2015 Oct; 35(10):1010-7. PubMed ID: 26275891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of consensus among healthcare professionals at a large academic medical center on the use of exome sequencing for prenatal diagnosis.
    Johnson K; Erfani H; Maktabi MA; Van den Veyver I; Nassef S
    J Genet Couns; 2022 Dec; 31(6):1330-1340. PubMed ID: 35799470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Couples experiences of receiving uncertain results following prenatal microarray or exome sequencing: A mixed-methods systematic review.
    Harding E; Hammond J; Chitty LS; Hill M; Lewis C
    Prenat Diagn; 2020 Jul; 40(8):1028-1039. PubMed ID: 32362033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role and practice evolution for genetic counseling in the genomic era: The experience of Australian and UK genetics practitioners.
    Dwarte T; Barlow-Stewart K; O'Shea R; Dinger ME; Terrill B
    J Genet Couns; 2019 Apr; 28(2):378-387. PubMed ID: 30629777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient-centered prenatal counseling: aligning obstetric healthcare professionals with needs of pregnant women.
    Farrell RM; Nutter B; Agatisa PK
    Women Health; 2015; 55(3):280-96. PubMed ID: 25794055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternity health care professionals' views and experiences of fetal genomic uncertainty: A review.
    Hui L; Szepe E; Halliday J; Lewis C
    Prenat Diagn; 2020 May; 40(6):652-660. PubMed ID: 32096235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opening Pandora's box?: ethical issues in prenatal whole genome and exome sequencing.
    Horn R; Parker M
    Prenat Diagn; 2018 Jan; 38(1):20-25. PubMed ID: 28695688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Committee Opinion No. 682 Summary: Microarrays and Next-Generation Sequencing Technology: The Use of Advanced Genetic Diagnostic Tools in Obstetrics and Gynecology.
    Obstet Gynecol; 2016 Dec; 128(6):1462-1463. PubMed ID: 27875471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and Counseling Experiences of Early Adopters of Whole Exome Sequencing.
    Arora S; Haverfield E; Richard G; Haga SB; Mills R
    J Genet Couns; 2016 Apr; 25(2):337-43. PubMed ID: 26283062
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Views and preferences for the implementation of non-invasive prenatal diagnosis for single gene disorders from health professionals in the United Kingdom.
    Hill M; Karunaratna M; Lewis C; Forya F; Chitty L
    Am J Med Genet A; 2013 Jul; 161A(7):1612-8. PubMed ID: 23696422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Communication with patients during the prenatal testing procedure: an explorative qualitative study.
    van Zwieten M; Willems D; Knegt L; Leschot N
    Patient Educ Couns; 2006 Oct; 63(1-2):161-8. PubMed ID: 16406463
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ethical communication in clinical trials. Issues faced by data managers in obtaining informed consent.
    Loh WY; Butow PN; Brown RF; Boyle F
    Cancer; 2002 Dec; 95(11):2414-21. PubMed ID: 12436450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Physician Experiences and Understanding of Genomic Sequencing in Oncology.
    Weipert CM; Ryan KA; Everett JN; Yashar BM; Chinnaiyan AM; Scott Roberts J; De Vries R; Zikmund-Fisher BJ; Raymond VM
    J Genet Couns; 2018 Feb; 27(1):187-196. PubMed ID: 28840409
    [TBL] [Abstract][Full Text] [Related]  

  • 40. "Decoding" informed consent. Insights from women regarding breast cancer susceptibility testing.
    Geller G; Strauss M; Bernhardt BA; Holtzman NA
    Hastings Cent Rep; 1997; 27(2):28-33. PubMed ID: 9131350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.